| Bioactivity | CEP-40125 (RXDX-107) is a modified form of Bendamustine (HY-13567), a DNA cross-linking agent that may cause DNA damage and cell apoptosis. CEP-40125 (RXDX-107) is formed by encapsulating the alkyl ester form of Bendamustine in human serum albumin[1][2]. |
| CAS | 1456608-94-8 |
| Formula | C28H45Cl2N3O2 |
| Molar Mass | 526.58 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pharmaceutical prodrugs and methods of their preparation and use. WO2018013783. [2]. Croasdell G. The 34th Annual JP Morgan Healthcare Conference. San Francisco, California, USA-January 11-14, 2016[J]. Drugs of the Future, 2016, 41(1). |
CEP-40125
CAS: 1456608-94-8 F: C28H45Cl2N3O2 W: 526.58
CEP-40125 (RXDX-107) is a modified form of Bendamustine (HY-13567), a DNA cross-linking agent that may cause DNA damage
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.